SOL Group carries on its international expansion strategy in Spain.
05/12/2024Acquired the 51% of the Spanish Company SISEMED in strategic partnership with the Costaisa Group.
Acquired the 51% of the Spanish Company SISEMED in strategic partnership with the Costaisa Group.
SOL Group - a multinational operating in the technical, industrial and medicinal gases and home care sectors - announces that it has strengthened its presence in Spain through a new partnership with a major Spanish operator, in the clinical engineering sector.
More specifically, AIRSOL S.r.l. – a 100% SOL S.p.A.’s controlled subsidiary – acquired the 51% of the Spanish company SISEMED, specialized in the management of electromedical equipment, based in Barcelona.
The Costaisa Group, founded in Barcelona in 1968, created SISEMED in 2010 as an initiative to develop the medical technology services area. Today, SISEMED is a company specializing in clinical engineering, particularly in the management of electromedical equipment in hospitals.
In the fiscal year 2023, SISEMED recorded a turnover of about 8 million euros with a workforce of over 100 employees.
Costaisa remains as SISEMED shareholder with 49% of shares.
Aldo Fumagalli Romario, Chairman and Chief Executive Officer of SOL Group, declared:
"This transaction together with Costaisa Group represents another important step in the internationalization strategy adopted by SOL Group in the Iberian Peninsula, where we have been present for some time. It is also a further opportunity for us to consolidate our role as 360° healthcare operator, particularly in the hospitals in Spain and Portugal".
Luis Recolons, Chief Executive Officer at Costaisa Group, commented:
"The partnership with SOL Group will allow us to strengthen our position in the Iberian market, expanding the portfolio of products and services for our customers; moreover, thanks to this transaction, we will be able to evaluate international development opportunities together with SOL Group".
For more info, please read the Press Release.
share: